[1]Hundahl SA,Fleming ID,FremgenAM,et al. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the U. S,1985-1995[J]. Cancer,1998,83(12):2638-2648.
[2]Luo ShL,Yu M, Gong WW.The popularity of thyroid status and preventive factors[J]. China Preventiv Medicine,2013,14(4):317. (in Chinese)
罗胜兰,俞敏,龚巍巍.甲状腺癌的流行现况及其危险因素[J].中国预防医学杂志,2013,14 (4):317.
[3]Xiao DSh,Cao HQ,Deng ZhH,et al.Effect of FGF-2 and subcellur location of Smac in human small cell lung cancer cell NCIH446[J].Journal of Central South University (Medical Science),2008,33(8):705-711. (in Chinese)
肖德胜,曹慧秋,邓征浩,等.FGF-2对小细胞肺癌细胞株NCIH446 survivin表达及Smac亚细胞定位的影响[J].中南大学学报(医学版),2008,33(8):705-711.
[4]Liu W,Deng ZhH,Zhou JH,et al.Clinicopathological significance of FGF-2 and TRX expression in non-small cell lung cancer[J].China Journal of Modern Medicine,2010,20(5):1461-1465. (in Chinese)
刘玮,邓征浩,周建华,等.FGF-2和TRX在非小细胞肺癌中的表达及临床病理学意义[J].中国现代医学杂志,2010,20(5):1461-1465.
[5]Yao R,Sun J,Li ZhY,et al.Fibroblast growth factor 2 regulation of bone sialoprotein expression in human breast cancer cells[J].Journal of Logistics University of CAPF(Medical Sciences ),2013,22(5):348-350. (in Chinese)
姚睿,孙静,李正阳, 等.FGF-2对人乳腺癌细胞MCF7骨涎蛋白表达的影响[J].武警后勤学院学报(医学版), 2013, 22(5): 348-350.
[6]Gowardhan B,Douglas DA,Mathers ME,et al.Evaluation of the fibroblast growth factor system as a potential target for therapy in human prostate cancer[J].Br J Cancer,2005,92(2):320-327.
[7]Wang J,Stockton DW, Ittmann M.The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression[J].Clin Cancer Res,2004,10(18):6169-6178.
[8]Thussbas C,Nahrig J,Streit S,et al.FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer[J].J Clin Oncol,2006,24(23):3747-3755.
[9]Zhu CP,Yi ZhW.The expression of FGFR4 in the development of kidney and renal pathology [J].Contemporary Chinese Journal Pediatrics, 2007,9(2):133-138. (in Chinese)
朱翠平,易著文.成纤维细胞生长因子受体4在人发育肾和病理肾中的表达[J].中国当代儿科杂志,2007,9(2):133-138.
[10]Shereen E,Ping H,Alan D,et al.Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growth [J].Clin Cancer Res,2005,11(3):1336-1341.
[11]Rose K.Foscarnet reduces FGF2-induced proliferation of human umbilical vein endothelial cells and has antineoplastic activity against human anaplastic thyroid carcinoma cells[J].Biomed Pharmacother,2013, 67(1):53-57.
[12]St Bernard R,Zhang L, Liu W, et al. Fibroblast growth factor receptors as molecular targets in thyroid carcinoma[J].Endocrinology,2005,146(3):1145-1153. |